Wabash National Corporation Announces Intent to Seek New

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Wabash National Corporation Announces Intent to Seek New Senior Secured Term Facility

LAFAYETTE, Ind., March 3, 2015 (GLOBE NEWSWIRE) -- Wabash National Corporation ("Wabash" or "the Company") (NYSE: WNC ) today announced that on Thursday, March 5, 2015, it will launch a process intended to secure a new, $192.8 million Senior Secured Term Facility with an expected maturity in 2022, and the expected inclusion of other terms and conditions similar to the Company's existing Senior Secured Term Facility. The proceeds from a new Facility will be used to repay in full the outstanding balance on the Company's existing Senior Secured Term Facility, which matures on May 8, 2019. The process for the new Senior Secured Term Facility will be arranged by Wells Fargo Securities, LLC, and Morgan Stanley Senior Funding, Inc., as joint lead arrangers and joint bookrunners.

Jeff Taylor, Senior Vice President and Chief Financial Officer, said, "Wabash National's strong business performance, robust industry outlook, and solid financial position provide the opportunity to take this action as part of our ongoing commitment to prudently manage the overall financial risks of the Company and strengthen shareholder value. We believe this new facility and the terms we seek to obtain will lower our balance sheet risk well into the future and provide the flexibility to execute our capital allocation strategy of maintaining strong liquidity, deleveraging our balance sheet, returning capital to shareholders, and investing in the business, both organically and strategically."

Safe Harbor Statement

This press release contains certain forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements convey the Company's current expectations or forecasts of future events. All statements contained in this press release other than statements of historical fact are forward-looking statements. These forward-looking statements include statements about the ability to enter into a new senior secured term facility and the terms of that facility. These and the Company's other forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those implied by the forward-looking statements, including factors specific to the Company and to the credit market generally. Readers should review and consider the various disclosures made by the Company in this press release and in the Company's reports to its stockholders and periodic reports on Forms 10-K and 10-Q.

About Wabash National Corporation

Headquartered in Lafayette, Indiana, Wabash National Corporation (NYSE: WNC ) is a diversified industrial manufacturer and North America's leading producer of semi-trailers and liquid transportation systems. Established in 1985, the Company specializes in the design and production of dry freight vans, refrigerated vans, platform trailers, liquid tank trailers, intermodal equipment, engineered products, and composite products. Its innovative products are sold under the following brand names: Wabash National ® , Transcraft ® , Benson ® , DuraPlate ® , ArcticLite ® , Walker Transport, Walker Defense Group, Walker Barrier Systems, Walker Engineered Products, Brenner ® Tank, Beall ® , Garsite, Progress Tank, TST ® , Bulk Tank International and Extract Technology ® . To learn more, visit www.wabashnational.com .

Media Contact: Dana Stelsel Corporate Communications Manager (765) 771-5766 Investor Relations: Mike Pettit Vice President - Finance and Investor Relations (765) 771-5581

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Triumph Financial Sets Stage for Q4 Earnings and Insights

Updated Category News Views 196

Triumph Financial Plans Fourth Quarter Earnings Release Triumph Financial, Inc. (Nasdaq: TFIN) recently announced its anticipation for the release of fourth quarter financial results. This event is scheduled to take place after the market closes on an upcoming Wednesday. Along with the financial report, the company will provide management commentary for stakeholders and...

Continue Reading
Monitoring ABA Therapy Progress: A Parent's Guide

Updated Category News Views 6

The Nuts and Bolts of Progress Monitoring You've got a situation in Leominster where parents are trying to make sense of ABA therapy's impact on their kids. Rob Shapiro, a big name in the ABA world, breaks it all down in a HelloNation article. We're talking about precise data collection being the backbone of measuring progress in ABA therapy. This ain't no place for...

Continue Reading
Understanding Dowlais Group's Recent Market Activities

Updated Category News Views 185

Public Disclosure Regarding Dowlais Group's Trading Activity FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code 1. KEY INFORMATION (a) Name of exempt principal trader: Investec Bank plc (b) Name of offeror/offeree in relation to whose r

Continue Reading
OFS Credit Company Reports Impressive Q4 Financials for 2024

Updated Category News Views 98

OFS Credit Company Delivers Strong Q4 2024 Financial Results OFS Credit Company, Inc. (NASDAQ: OCCI), a notable investment firm focusing on collateralized loan obligation (CLO) equity and debt securities, has announced its financial performance for the fiscal quarter ending October 31, 2024. This report outlines the company’s significant financial growth and strategic...

Continue Reading
Breakthrough Data on HBI-8000 and Nivolumab for Melanoma

Updated Category News Views 89

HBI-8000 and Nivolumab: A New Era in Melanoma Treatment Recent findings highlight the potential of HBI-8000 in combination with nivolumab, suggesting a transformative approach in the treatment of advanced melanoma. This promising combination will be discussed in detail at an upcoming prestigious annual meeting focused on advancements in immunotherapy. Innovative Solutions...

Continue Reading